U.S. Home Infusion Therapy Market - Industry Statistics Report 2024

Sellbyville, DE -- (SBWire) -- 10/30/2018 --The U.S. Home Infusion Therapy Market is set to exceed USD 13.5 billion by 2024; according to a new research report by Global Market Insights. Increasing rates of hospital acquired infections have impacted the market growth positively. In American hospitals, infections associated with health care account for around 1.7 million infections and 99,000 deaths every year.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2641

These infections lead to chronic diseases that require continuous monitoring; thus, accelerate demand for home infusion therapies. Increasing number of immunocompromised patients that are more prone to infections will fuel industry growth over the coming years. Furthermore, growing preference for home infusion therapies due to ease and convenience will boost home infusion therapy market growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1.Baxter International Inc.
2.Smiths Medical
3.Terumo Medical Corporation
4.Becton Dickinson
5.Fresenius Kabi USA
6.Halyard Health
7.ICU Medical
8.Amsino International Inc.
9.BKK B. Braun Melsungen AG
10.CME (Caesarea Medical Electronics Ltd.)

Presence of home healthcare facilities such as home health care agencies, hospice and home care aide organizations as an alternative to hospitals and clinics will fuel industry growth. According to AARP, persons aged 50 years or older suffering with chronic disorders prefer independent living in homes over other alternatives. Low prices offered by home healthcare facilities have resolved the affordability issues faced by the geriatric population that have relatively low-income levels. Aforementioned factors coupled with increasing surgical procedures have flourished the growth of home infusion therapy market. Increasing geriatric population base drives the market growth. However, healthcare insurance policies developed by the policy providers such as Medicare and Medicaid provide insufficient reimbursement that proves to be a major restraint creating affordability issues for geriatric population suffering from chronic diseases.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2641

Infusion pumps accounted for largest revenue share in 2017 due to rising number of baby boomers, highly susceptible to suffer from infections and requires continuous delivery of fluids for maintaining proper health. Growing demand for home infusion therapy services are anticipated to fuel business growth.

U.S. Home Infusion Therapy Market by Product

Infusion pump
Intravenous sets
IV cannulas
Needleless connectors

U.S. Home Infusion Therapy Market by Application

Anti-infectives
Hydration therapy
Chemotherapy
Enteral nutrition
Parenteral nutrition
Specialty pharmaceuticals